Conference Overview

Pharma Security World 2018 - Anti-Counterfeiting & Brand Safety Conference


The pharmaceutical industry has an array of duties of keeping up with technology and research as well as the unbridled counterfeit products that can thwart the efforts. The snide, intended to mimic the genuine products, have in many cases led to lack of effective healing, adverse reactions and now the diminishing confidence in medicines and the general healthcare systems and the providers of the same.


With sales ranging from €150 billion to €200 billion which is US$163 billion to $217 billion every year, as indicated by industry estimates, fake pharmaceuticals are the most lucrative segment of the worldwide exchange illicitly replicated merchandise. World Health Organization (WHO) approximates 30 percent of drugs that reach developing nations are counterfeit and this can have substantial effects for the brand as well as on the patients. Dealing in counterfeits is a criminal offence that not only harms legitimate businesses, but also leaves consumers with sub-standard goods that are often precarious.

Thus Counterfeit medicines are turning into a serious concern around the world, and have progressively been showing up through the real pharmaceutical supply chain, including community and online drug stores. Whats more, pharmaceutical companies and regulators are creating ways to stop them. No nations stay untouched by this issue, what was once viewed as an issue endured by developing nations has now turned into an issue to developing nations including US and Europe. We require both countrywide and industry-level participation, and in addition public and private sector coordinated effort, to identify and definitively battle counterfeiters.


The US is driving the path with the Drug Supply Chain Security Act (DSCSA) approved in 2013. DSCSA guide for end-to-end traceability is extended over a period of 10 years, with expectations sketched through out the supply chain. In the US, lot- level traceability started in January 2015 under the under the act with package-level serialization to be finished in November 2017. The complete supply chain is relied upon to be electronically incorporated and all hubs of traceability to be built up by November 2023. The E.U.’s Falsified Medicines Directive requires drug companies
to adopt mass serialization and other anti-counterfeiting measures starting in 2019. Manufacturers who operate in the E.U. will have to add unique identification numbers to the outer packaging of all prescription drugs, and equip containers with tamperproof seals. To guide customers from illicit online drug stores that supply fake medications, the FMD requires approved legitimate Internet drug stores to show a logo distinguishing them as E.U. approved drug retailers.


To protect your brand and build a genuine future, Corvus Global Events invites you to Pharma Security World 2018 – An Anti-counterfeiting & Brand Safety Conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations.


It gives us a great pleasure to welcoming you to the Pharma Security World 2018

Key Highlights

  • Understanding and meeting the needs of DSCSA, EU FMD and other global regulations
  • Synchrony of the Pharma Industry and professional bodies against counterfeiting
  • Tackling pharmaceutical crime - initiatives at multinational, EU and national level
  • IP and regulatory enforcement
  • Strategies for public awareness and patient protection
  • Best practices to protect your brand
  • The role of the Internet in aiding the counterfeiters – How to overcome the situation?
  • Common Logo initiative in the EU for online pharmacies
  • Brand Protection & Securing supply chain integrity
  • End to End supply chain visibility
  • Developing a sustainable Serialization strategy
  • Global enterprise level solutions for anti-counterfeiting
  • Integration of track & trace solutions in production and supply chain
  • Smart Packaging, Labeling, Artwork, Warehouse & Logistics 
  • Effective Authentication Technologies
  • Best selection of tamper-evident features
  • Developing a RMP for your supply chain to protect your Brand, Product and Patient Safety
  • Measuring the Effectiveness of a Good Quality System through frequent external and internal audits
  • Debating the use and implementation of serialization, barcoding, and RFID
  • Serialization Data and Analytics driven approach to increase supply chain agility
  • Cloud-based technology complement big data solutions in monitoring and improving supply chain processes
  • The need to understand and adopt new technologies like IoT, Analytics, Block chain, Machine Learning and Artificial Intelligence
  • Case study: How companies are structuring their counterfeiting efforts and departments?

Who should attend the conference

Attendees include GMs, VPs, Directors, Heads and Managers of:

  • Intellectual Property, investigators and Trademark council
  • Law enforcements & legal services
  • Drug regulatory agencies and customs
  • Pharmaceutical manufacturers and distributors
  • Healthcare professionals
  • Pharmacists
  • Serialization, Track and Trace solution providers
  • Brand protection, enforcement, security, integrity and management companies
  • Healthcare research organizations
  • Pharmaceutical industry professional associations
  • Anti-counterfeiting organizations
  • Supply Chain management companies
  • Packaging, labeling and converting companies
  • Authentication technology suppliers
  • Contract manufacturing organization (CMO)
  • IT service providers


There are plenty of opportunities to position yourself as a thought leader & showcase your company.

For enquiries on speaker opportunities please e-mail to

Day 1 -

Tuesday - 20th March 2018


  • 08:30
  • Registration & Refreshments

  • 09:20
  • Chairperson's opening remarks


  • 09:30
  • A multi-layered approach is the way to go for optimal brand protection 

    • Develop a strategy protecting the patient safety, brand reputation, intellectual property rights and revenue
    • Guidelines to prevent counterfeit from entering the supply chain
    • Monitoring the complex counterfeiters threatening enforcement efforts
    • Create a team which has experts from Law enforcement, supply chain, packaging technology and legal
    • Develop best practices for counterfeit detection, prevention and deterrence
    • Develop & implement a counterfeit risk assessment tool

    Patrick Holt Director, Global Security EMEA, Pfizer

  • 10:00
  • Worldview of Counterfeit drugs - The evolving counterfeit challenges

    • The common Anti-counterfeiting strategies in EU, US and the rest of the world to handle the counterfeit medicines
    • Identification of countries severely affected by the counterfeit medicines
    • The challenges of combating counterfeit medicines in most affected countries
    • The loopholes in various legislations encouraging gray market to thrive

    Speaker TBA Integra  

  • 10:30
  • Morning Coffee/Tea & Networking

  • 10:50
  • Understanding illicit markets and establishing strategic responses to disrupt the threats that supply them

    • Supply and demand drivers
    • Synergies between illicit drug markets and counterfeit pharmaceuticals
    • Strategic response design and delivery

    Tony SaggersDirector of StraTac Logical Limited(Former Head of Drugs
    Threat & Intelligence - National Crime Agency)

  • 11:20
  • Is your organization ready for DSCSA, EU FMD and Other Global Regulations?

    • How to define and successfully implement your strategy for global regulatory
    • Identyfying and Implementing the new traceability and interoperability capabilities
    • Aligning with global standards


  • 11:50
  • Advancement in IP enforcement in Europe and what’s next?

    • New EU initiatives to counter growing IPR infringement and counterfeits
    • Reducing Intellectual Property Crime through Effective Partnerships
    • Intellectual property rights (IPR) laid down by the World Intellectual Property Organisation(WIPO)
    • Brexit: English Intellectual Property law implications
  • 12:20
  • How the Internet is used by the criminal networks, what are the current trends and what companies can do to disrupt this activity

    Stephen TruickDirector - Internet Infrastructure Investigation,
    Former Consultant Internet Infrastructure Manager, MHRA

  • 12:50
  • Networking & Luncheon

  • 13:30
  • How to better engage and assure full compliance from external partneship using a bayer’s external manufacturing’s governance model

    Luiz Alberto BarberiniExternal Manufacturing Organization latam Head, Bayer

  • 14:00
  • The importance of rigorous computer system validation testing and staff training in meeting the regulatory requirements of the EU FMD, DSCSA and other global regulations

    Mark Lund-ConlonAdobe eSign 21 CFR 11 Validation Test Lead, GE Healthcare

  • 14:30
  • Fighting fakes by raising public awareness

    • Legitimate vs Illegitimate supply chain
    • The rising threat of websites selling falsified medicines – tackling the supply side
    • Raising public awareness to tackle the demand side – who has a stake?

    Mike IslesExecutive Director, The European Alliance
    for Access to Safe Medicines(EAASM)

  • 15:00
  • Afternoon Tea/Coffee

  • 15:20
  • Combating the rise of global online pharmacies - Are we underestimating the threat?

    • Approaches to authenticate the online pharmacy
    • Will E.U.’s Falsified Medicines Directive help in controlling the interent pharmacies?
    • Improved regulation of online pharmacy market
    • Educating the public on what falsified medicines are and the risks that they pose
    • Collaboration and coordination of multiple stakeholders through out the supply chain
    • A public–private partnership model
  • 15:50
  • Case Study: How Roche manages confirmed counterfeit cases at a worldwide level. From the information about a counterfeit case to the answer given to Health Authorities and potential field actions or initiation of a criminal investigation.

    Hugues IselHead of Global Complaint Management Europe,
    F.Hoffmann-La Roche

  • 16:20
  • Panel Discussion: Creating a joint anti-counterfeiting approach - Enhancing a coherent relationship between all stakeholders of both private and public sector

    To fight against product counterfeiting, the brand owners, law enforcement agencies, industry associations, service providers, government agencies and others should come together sharing their ideas and perspective

    • What needs to be done to collaborate at all levels – Regional, National and International
    • Harmonizing the legal framework for anti-counterfeiting and anti-piracy
    • How are Interpol, Europol and the United Nations Office of Drugs and Crime are fighting against counterfeiting?
    • Role of the international organizations (WHO, WIPO, WTO etc.) in preventing the counterfeit medicines entry into the world markets

    Jeremy Newman,Principal, Rouse Consultancy (Chair of EU
    Anticounterfeiting subcommittee (2016-17),
    International Trademark Association (INTA)

  • 17:00
  • Chairperson’s closing remarks

  • 17:10
  • Networking Drinks Session

Delegate Registration

Corvus Global Events recognises the value of learning in teams. There's so much great content!!!

Bring your team and get an extra discount. There are special group packages available. Please email to delegate@corvusglobalevents.comfor more details.


Maximise Your Involvement through Sponsorship and Exhibition Opportunities Our Sponsors are an integral part of the CGE Conference and we want to ensure you receive the best possible results for your investment. Exhibiting and Sponsorship options are extensive, and packages can be tailor-made to suit your individual company's needs. Most packages include complimentary entry passes, targeted marketing to industry officials and executives, and bespoke networking opportunities.

For enquiries please e-mail to


EXTEDO's focus is on optimizing clients' eRegulatory business processes. The company's enabling technology, the EXTEDOsuite, is uniquet in that it covers the complete regulatory landscape including:Product Registration Planning & Tracking (XEVMPD & IDMP)Submission Publishing & Lifecycle Management (eCTD, CTD, NeeS, IMPD, CTA, eCopy, DMF, ASMF, VNeeS, CADDY, ePRISM, eIndex) Pharmacovigilance Management (SUSAR, ICSR, PSUR, E2B, MedDRA, SMQ, GvP, CIOMS, MedWatch, R3) andDocument Management
We offer configurable off-the-shelf products, as well as customized and integrated solutions compliant with Medical Product Dictionary. EXTEDO also provides EURS, the validation, review and approval software solution for the EMA and over 25 Regulatory Authorities worldwide. Today we serve more than 700 customers in 60 countries ranging from small companies to large multinational organizations. EXTEDO operates in the following areas of life sciences: pharmaceutical, biotech and biopharma, generics, homeopathics, medical devices, crop sciences and public sector. EXTEDO is recognized as one of the worldwide leaders in each of these areas of operation.


Partnerships typically involve an exchange of value and frequently include online content, PR, advertising, online & event branding.

For enquiries please e-mail to



We make every effort to secure
the very best hotels for our attendees

Holiday Inn London - Kensington


Wrights Lane, Kensington


London W8 5SP


United Kingdom

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now